MX2010009507A - Combinacion que comprende un compuesto que se enlaza con los receptores de cannabinoides, y un opioide. - Google Patents
Combinacion que comprende un compuesto que se enlaza con los receptores de cannabinoides, y un opioide.Info
- Publication number
- MX2010009507A MX2010009507A MX2010009507A MX2010009507A MX2010009507A MX 2010009507 A MX2010009507 A MX 2010009507A MX 2010009507 A MX2010009507 A MX 2010009507A MX 2010009507 A MX2010009507 A MX 2010009507A MX 2010009507 A MX2010009507 A MX 2010009507A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor binding
- cannabinoid receptor
- opioid
- binding compound
- combination
- Prior art date
Links
- 102000018208 Cannabinoid Receptor Human genes 0.000 title abstract 3
- 108050007331 Cannabinoid receptor Proteins 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000002790 naphthalenes Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152104 | 2008-02-28 | ||
| PCT/EP2009/052297 WO2009106574A2 (en) | 2008-02-28 | 2009-02-26 | Combinations for treating hiv-associated pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010009507A true MX2010009507A (es) | 2010-09-24 |
Family
ID=39415383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010009507A MX2010009507A (es) | 2008-02-28 | 2009-02-26 | Combinacion que comprende un compuesto que se enlaza con los receptores de cannabinoides, y un opioide. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090281194A1 (https=) |
| EP (1) | EP2257281A2 (https=) |
| JP (1) | JP2011513278A (https=) |
| KR (1) | KR20100126441A (https=) |
| CN (1) | CN101945650A (https=) |
| AU (1) | AU2009218456A1 (https=) |
| BR (1) | BRPI0907805A2 (https=) |
| CA (1) | CA2716405A1 (https=) |
| EA (1) | EA201001363A1 (https=) |
| MX (1) | MX2010009507A (https=) |
| WO (1) | WO2009106574A2 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| GB0012795D0 (en) * | 2000-05-25 | 2000-07-19 | Novartis Ag | Organic compounds |
| GB0028702D0 (en) * | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
| US8449908B2 (en) * | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
| GB0504950D0 (en) * | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
| US20090029984A1 (en) * | 2005-07-11 | 2009-01-29 | N.V. Organon | Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid receptor agonist) |
-
2009
- 2009-02-26 BR BRPI0907805-3A patent/BRPI0907805A2/pt not_active IP Right Cessation
- 2009-02-26 CA CA2716405A patent/CA2716405A1/en not_active Abandoned
- 2009-02-26 EP EP09715296A patent/EP2257281A2/en not_active Withdrawn
- 2009-02-26 EA EA201001363A patent/EA201001363A1/ru unknown
- 2009-02-26 KR KR1020107021410A patent/KR20100126441A/ko not_active Withdrawn
- 2009-02-26 MX MX2010009507A patent/MX2010009507A/es not_active Application Discontinuation
- 2009-02-26 JP JP2010548108A patent/JP2011513278A/ja active Pending
- 2009-02-26 WO PCT/EP2009/052297 patent/WO2009106574A2/en not_active Ceased
- 2009-02-26 CN CN2009801054260A patent/CN101945650A/zh active Pending
- 2009-02-26 AU AU2009218456A patent/AU2009218456A1/en not_active Abandoned
- 2009-03-02 US US12/395,980 patent/US20090281194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA201001363A1 (ru) | 2011-04-29 |
| AU2009218456A1 (en) | 2009-09-03 |
| JP2011513278A (ja) | 2011-04-28 |
| BRPI0907805A2 (pt) | 2015-07-14 |
| WO2009106574A2 (en) | 2009-09-03 |
| CN101945650A (zh) | 2011-01-12 |
| WO2009106574A3 (en) | 2009-12-17 |
| CA2716405A1 (en) | 2009-09-03 |
| US20090281194A1 (en) | 2009-11-12 |
| EP2257281A2 (en) | 2010-12-08 |
| KR20100126441A (ko) | 2010-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012253757A8 (en) | Partially saturated tricyclic compounds and methods of making and using same | |
| WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
| WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| TN2011000414A1 (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
| IN2012DN02805A (https=) | ||
| EP2679234A3 (en) | Binding proteins that bind to human FGFR1C, human beta-klotho and both human FGFR1C and human beta-klotho | |
| UA111464C2 (uk) | Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу | |
| EP4414376A3 (en) | Novel depsipeptide and uses thereof | |
| WO2012154679A8 (en) | Tricyclic pyrazole sulfonamide compounds and methods of making and using same | |
| UA99540C2 (ru) | Замещенные мостиковым хиноксалином пиперидиновые соединения и их применение | |
| MY156275A (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| IL220894A (en) | Combinations of active substances containing dihydroporone and abamctin | |
| WO2013178965A3 (fr) | Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau | |
| TW200942530A (en) | Pyridine compounds | |
| PH12012500773A1 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| WO2009062576A3 (en) | Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same | |
| WO2011161396A3 (en) | Disinfectant composition | |
| IL207205A0 (en) | Triazolopyridazines as par1 inhibitors, their preparation and use as medicaments | |
| WO2011139252A3 (en) | Efervescent formulations comprising cefdinir | |
| WO2010042212A3 (en) | Methods for treating or preventing pain using spicamycin derivatives | |
| WO2010075086A3 (en) | Pyrrolidinone inhibitors of pde-4 | |
| TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |